April 1, 2016, Coralville, IA – Emmyon is pleased to announce that it has received a new Phase I SBIR award from the National Institutes of Health. The funding will support development of pharmaceuticals for skeletal muscle atrophy and weakness.
By redilson
April 1, 2016, Coralville, IA – Emmyon is pleased to announce that it has received a new Phase I SBIR award from the National Institutes of Health. The funding will support development of pharmaceuticals for skeletal muscle atrophy and weakness.